Tarus Therapeutics, Inc.
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Sushant
ADPORT-601, NCT04969315: TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors

Active, not recruiting
1/2
90
US
TT-10
Portage Biotech, Tarus Therapeutics, Inc.
Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
05/25
08/25

Download Options